Cary Research Group (Site 111) — Cary, North Carolina

Cary Research Group (Site 111) is a clinical research site located in Cary, North Carolina, United States 27518.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Cary Research Group (Site 111) has participated in 1 clinical trials.

Therapeutic areas: COVID-19.

Sponsors: Sagent Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cary Research Group (Site 111)?

Cary Research Group (Site 111) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cary Research Group (Site 111) conducted?

Cary Research Group (Site 111) has 1 clinical trials on record. Their work covers COVID-19.

Is Cary Research Group (Site 111) accredited by Crixeo Health?

Cary Research Group (Site 111) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cary Research Group (Site 111)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.